Download Dr. Vincent Giampapa Receives Nobel Prize Nomination for Stem

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Signal transduction wikipedia , lookup

Tissue engineering wikipedia , lookup

Endomembrane system wikipedia , lookup

Cell encapsulation wikipedia , lookup

Cell cycle wikipedia , lookup

Extracellular matrix wikipedia , lookup

Cell growth wikipedia , lookup

Cytokinesis wikipedia , lookup

Mitosis wikipedia , lookup

Cell culture wikipedia , lookup

Amitosis wikipedia , lookup

Organ-on-a-chip wikipedia , lookup

JADE1 wikipedia , lookup

Cellular differentiation wikipedia , lookup

Somatic cell nuclear transfer wikipedia , lookup

List of types of proteins wikipedia , lookup

Transcript
For Immediate Release
Dr. Vincent Giampapa Receives Nobel Prize Nomination for Stem Cell Research
The creator of HealthyCell gets highest honor in Stem Cell Research
25 Inc. the creators of TrepScore™, a transparency platform that provides execution analytics for
startups, recognizes and congratulates one of its earliest adopters, Dr. Vincent Giampapa and his
research team at Rutgers University for their recent nomination for a 2014 Nobel Prize in the area of
Stem Cell Research.
The Nobel Prize Nomination was awarded for the potential impact Dr. Giampapa’s technology may have
on the global aging epidemic as well as the financial impact of future health care in all countries with
aging demographics, especially in the United States.
After 2 years of research on the effects of young cells on old cells Dr. Vincent Giampapa and Dr. Pranela
Rameschwar have appeared to reverse the cellular aging process in humans as documented by changes
in genes and proteins as well as cell function. “We could not have made this breakthrough without the
funding and support of two very important people, Mr. John Malone of Liberty Media and Dr. Ed
Bosarge” said Dr. Vincent Giampapa.
Originally presented by Dr. Giampapa in Rome at the Vatican Stem For Life meeting in April 2013 and
then again in Stockholm at the Swedish American Life Science Summit his research has documented the
in-vitro approach can make cellular restoration possible.
Dr Giampapa is an attending physician at Hackensack Medical Center and Associate Clinical Professor at
UMDNJ- Medical Center in New Jersey, is also founder of the Cell Health Institute. He has also received
the EDISON Award this past year for innovation in the design of HealthyCell™, a new oral supplement
based on natural plant extracts that helps keep cells healthier longer.
“We could not be more proud of the accomplishments of Dr. Giampapa and the research team at
Rutgers University on their nomination for the Nobel Prize. We hope to see them holding the award
later in the year as the winner” said Eric Rice, Founder and CEO of TrepScore™.
About The HealthyCell™
CellHealth Institute is a biotech company committed to empowering people to lead healthier lives. The
company focuses on combined cellular health products, such as healthycell™, along with its innovative
cell health services and holistic lifestyle education in service of its mission is to help people take control of
their health at the fundamental cell level.
About TrepScore™
Founded by entrepreneurs and investors, TrepScore provides execution analytics for startups and private
companies. Its dynamic two-way platform provides entrepreneurs a simple and easy way to manage their
businesses and verified investors real-time, first-party data to make faster, more informed decisions.
TrepScore is currently closing out funding and is expected to launch in late summer 2014.